https://www.biopharmadive.com/news/pfizer-duchenne-gene-therapy-phase-3-sarepta/592936/
Pfizer beats Sarepta to start of first late-stage Duchenne gene therapy trial | BioPharma Dive
late stage duchennepfizer
https://www.statnews.com/2025/07/18/sarepta-elevidys-deaths-duchenne-muscular-dystrophy-dmd-mothers-research-progress/
Sarepta gene therapy deaths must not halt Duchenne progress | STAT
Jul 21, 2025 - We’ve come so far against Duchenne, two mothers say. Despite recent setbacks, we must keep going — and save room for risks.
sarepta gene therapydeaths
https://www.statnews.com/2019/11/12/solid-biosciences-duchenne-gene-therapy-trial-halted-after-patient-suffers-serious-toxicity/
Solid's Duchenne gene therapy trial halted after patient suffers toxicity
Nov 12, 2019 - This is the third time that the Cambridge, Mass.-based Solid has run into a serious safety problem with its gene therapy, called SGT-001.
duchenne gene therapysolid